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Abstract
Author Manuscript

Generalized anxiety disorder (GAD) and unipolar depressive disorders (UDD) have been shown to
differ from each other in dimensions of affective functioning despite their high rates of
comorbidity. We showed emotional film clips to a community sample (n = 170) with GAD, GAD
with secondary UDD, or no diagnosis. Groups had comparable subjective responses to the clips,
but the GAD group had significantly lower heart rate variability (HRV) during fear and after
sadness, compared to controls. While HRV in the GAD and control groups rose in response to the
sadness and happiness clips, it returned to baseline levels afterwards in the GAD group, potentially
indicating lesser ability to sustain attention on emotional stimuli. HRV in the GAD + UDD group
changed only in response to sadness, but was otherwise unvarying between timepoints. Though
preliminary, these findings suggest comorbid UDD as a potential moderator of emotional
responding in GAD.
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Generalized anxiety disorder (GAD) is highly comorbid with unipolar depressive disorders
(UDD) including major depressive disorder and dysthymia (Hoffman et al. 2008; Kessler et
al. 2005). Efforts to differentiate transdiagnostic from disorder-specific features of GAD and
UDD continue to represent a challenge for both research and clinical efforts; perhaps
consequently, these disorders tend to be most disabling and refractory to treatment when
they co-occur (Barrera and Norton 2009; Garcia et al. 2015; Mennin and Fresco 2013;
Zimmerman and Chelminski 2003). Given considerable genotypic and phenotypic overlap in
addition to lifetime and concurrent comorbidity, some scholars suggest that GAD and UDD
are better subsumed under a broader category of ‘distress disorders’ within a hierarchical
structure of arousal and positive and negative affect (e.g., Brown et al. 2001; Gorwood 2004;
Watson 2005). A counterpoint to these structural models comes from the difficulty they have
in accounting for contextual factors, or functional relationships in affective functioning (e.g.,
Brown and Barlow 2005; see Mennin et al. 2008). In order to discriminate disorder-specific
phenomena from transdiagnostic markers of psychopathology, it will be important to clarify
the nature of response heterogeneity, or differences in response to emotion, as a function of
comorbidity. In this study, we examined physiological response to emotion-eliciting film
clips in a large community sample of adults with GAD or GAD with secondary UDD, and
non-diagnosed controls.
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Emotions provide us with a sense of our goals and needs and facilitate our ability to make
decisions and navigate our environment (e.g., Frijda 1986). Yet, intensely-felt emotions can
also become highly distressing and disabling (Gratz and Roemer 2004; Gross and Jazaieri
2014). The arousal associated with normal emotional experiences, even positive experiences,
can feel unpleasant or even threatening, and thus become translated as anxiety to individuals
with GAD (e.g., Llera and Newman 2014; Mennin et al. 2007). Worry functions as an
attempt to dampen this arousal, or to attenuate aversive shifts between contrasting emotional
states—for example, joy and disappointment (e.g., Borkovec et al. 2004; Llera and Newman
2014). Much distress in UDD as well as in GAD stems from internally-mediated attempts to
manage emotions (e.g., Borkovec et al. 2004; Fresco et al. 2002; Kertz et al. 2012; Mennin
and Fresco 2013; Nolen-Hoeksema et al. 2008). However, UDD is marked by dampened
intensity and reactivity, in contrast to the typically heightened emotionality associated with
GAD (e.g., Mennin and Fresco 2015; Rottenberg et al. 2005a).
One mechanism through which heightened intensity might give rise to later blunted
emotional responding is the prolonged suppression of autonomic arousal associated with
chronic worry (e.g., Borkovec et al. 2004). Autonomic nervous system (ANS) activity is a
central part of how we experience emotions (Bradley and Lang 2000; Gross 1998; Kreibig
2010). Heart rate variability (subtle beat-to-beat changes in heart rate) results from
fluctuating ANS influence on cardiac function (see Shaffer et al. 2014). HRV is thought to
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reflect the functional integrity of a central autonomic network that plays an integral role in
facilitating communication between brainstem and forebrain structures (e.g., hypothalamus,
amygdala, medial prefrontal cortex) and visceral organs, including the heart, in service of
self-regulation (see Thayer et al. 2012). Typically, non-anxious individuals demonstrate
rapid physiological adaptation to stressors, reacting strongly to threats, but then returning
quickly to baseline once the threat is past. However, chronically anxious individuals show
weaker responses and delayed recovery (e.g., Hoehn-Saric and McLeod 2000; Lyonfields et
al. 1995). HRV is a well-suited measure of this type of flexible (or inflexible) responding, as
an index of the ability to dynamically adjust to physical, cognitive and emotional challenges
in the environment (e.g., Appelhans and Luecken 2006; Geisler et al. 2010; Porges 2007;
Thayer and Lane 2000). Decreased HRV is associated with inhibitory deficits common to
GAD such as threat bias, perseveration, and prolonged physiological arousal (Friedman
2007; Thayer and Lane 2009). Lower HRV in GAD may indicate a defensive and
disorganized response style in which physiological rigidity mirrors an inflexible cognitive
and behavioral repertoire that is typified by worry and avoidance (e.g., Aldao and Mennin
2012; Movius and Allen 2005; Thayer et al. 1996).
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Numerous studies support an association between anxiety disorders and decreased HRV
(Chalmers et al. 2014). However, not all studies have shown significantly different resting
state, or tonic, HRV in individuals with GAD relative to controls (e.g., Aldao and Mennin
2012; see Chalmers et al. 2014). Importantly, the extant literature suggests that there may be
moderators of the reduced HRV in GAD. One such factor is likely to be the presence of
comorbid UDDs. Decreased parasympathetic activity may underlie the higher rates of
cardiovascular disease observed in major depressive disorder (MDD; e.g., Nahshoni et al.
2004; Udupa et al. 2007; van der Kooy et al. 2006). However, lower tonic HRV may not
represent a stable and robust marker of depression (c.f. Brunoni et al. 2013); for example,
the meta-analysis by Rottenberg (2007) found that MDD diagnosis explained just 2 % of
overall variance in tonic HRV. Decreased tonic HRV may also be secondary to
anticholinergic properties of some antidepressants (e.g., Kemp et al. 2014a; Licht et al.
2008), or attendant symptoms of depression such as low mood or poor sleep (Bylsma et al.
2014; Salomon et al. 2013). By contrast, there is more consistent support for dysregulated
HRV in at the phasic level in MDD, evidenced by decreased physiological reactivity to
emotional stimuli (e.g., Rottenberg et al. 2005a; Rottenberg et al. 2007; Salomon et al. 2009;
Yaroslavsky et al. 2013). This dampened reactivity reflects a larger pattern of ‘emotional
context insensitivity’ which may represent an endophenotype for depression (Bylsma et al.
2008; Yaroslavsky et al. 2014).
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Few studies have explored how HRV responses to emotion in GAD might vary as a function
of comorbid depression. Kemp and colleagues (2012) found decreased HRV in patients with
MDD, compared to individuals with no psychiatric diagnosis; further, the comorbid MDD +
GAD group exhibited the lowest HRV relative to MDD-only and control groups. Likewise,
in a sample of Taiwanese patients, individuals with GAD and comorbid MDD showed the
lowest levels of HRV relative to individuals with GAD alone, though HRV was reduced in
both groups relative to controls (Chang et al. 2013). However, both studies focused solely on
tonic HRV. In contrast to the above studies, Hofmann and colleagues (2010) found that GAD
individuals without comorbid MDD displayed consistently lower HRV than those with
Cognit Ther Res. Author manuscript; available in PMC 2016 September 20.
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comorbid depression throughout experimentally-induced worry and relaxation as well as at
baseline. Examining HRV on a phasic level (i.e., in the context of emotional responding)
may therefore provide additional insight into the role of emotional experience in GAD
psychopathology. Indeed, Llera and Newman (2010) found that worry increased general
negative affect in individuals with GAD, yet decreased both physiological and/or subjective
reactivity to fear and sadness stimuli. Although the greater cognitive load associated with
chronic worry alone has been suggested to underlie the relationship between GAD and
decreased HRV, other studies have demonstrated reduced HRV in emotional contexts
independent of worry (e.g., Pieper et al. 2007; Verkuil et al. 2009), and it will be important
to clarify whether dysregulated physiological activity in emotional contexts represents a
transdiagnostic or disorder-specific feature of GAD and comorbid depression.

Author Manuscript

It is also notable that no study to date has yet specifically examined the impact of comorbid
UDD (either dysthymia or major depressive disorder) on HRV in GAD. While there have
been few HRV studies specifically contrasting dysthymia to MDD, there is some evidence
that there may not be meaningful differences between these diagnostic categories. For
example, Harte et al. (2013) found no differences in HRV between participants in their
sample with dysthymia versus those with MDD, and suggest that the specific diagnosis may
not have an effect on HRV above and beyond simply meeting the diagnostic threshold for a
depressive disorder. Given that MDD and dysthymia have similar rates of comorbidity with
GAD (e.g., Watson 2005), a sample featuring GAD individuals with comorbid UDD, rather
than MDD alone, should increase ecological validity of any observed effects.
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In the current study, we presented film clips used widely in previous studies of emotion and
HRV (e.g., Rottenberg et al. 2007) to a community sample of adults in three groups: a)
individuals with GAD alone, b) individuals with primary GAD with secondary UDD (GAD
+ UDD), and c) healthy controls. We recorded subjective and physiological responses to
emotional (fear, sad, happy) film clips, as well as at baseline and during a brief recovery
period. We predicted that individuals with GAD and GAD + UDD would show distinct
patterns of physiological response to emotion that differed from controls and from each
other. We expected that GAD + UDD and non-comorbid GAD groups would exhibit
different patterns of HRV responses to the film clips such that individuals with GAD alone
would show more phasic activity across the experiment as a function of heightened
emotional intensity, whereas those with GAD + UDD would show a less differentiated
pattern of HRV response to emotional contexts. This was based on earlier similar
investigations (e.g., Aldao et al. 2013; Hofmann et al. 2010; Llera and Newman 2010), as
well as evidence from prior studies suggesting that comorbid depression may moderate
heightened emotional reactivity in GAD and other anxiety disorders (e.g., Taylor-Clift et al.
2011; Weinberg et al. 2012). Finally, we expected to see that self-reported emotion across
the experiment would differ between GAD-only and comorbid GAD + UDD groups in one
of two directions: 1) that the GAD + UDD group would demonstrate blunted subjective
emotion reactivity (i.e., lower affect ratings) across emotional contexts, or 2) that negative
affect ratings would be elevated in the GAD + UDD group as a function of greater severity.
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Method
Participants
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As part of two larger studies of emotion in affective disorders, individuals with and without
GAD and depressive disorders were recruited from the greater New Haven, CT (n = 138)
and Kent, OH communities (n = 38) surrounding Yale and Kent State Universities through
flyers placed in local papers, on campus, and online through Craigslist (http://craigslist.org).
Criteria for inclusion in the present sample were a primary DSM-IV diagnosis (American
Psychological Association 2013) of either GAD (n = 58) or primary GAD with secondary
unipolar depressive disorder (GAD + UDD; MDD n = 22, dysthymia n = 14). Controls (n =
76) met no criteria for any diagnosis. Individuals with a primary diagnosis of any other
Axis-I disorder— including psychotic, adjustment, substance, or bipolar disorders—were
ineligible to participate. Also ineligible were participants with a systemic medical condition
(e.g., heart disease, epilepsy), or who were currently taking medications known to directly
affect cardiac function (e.g., beta blockers). The majority of the sample as a whole identified
as female (64.8 %) and White (63.6 %), with a mean age of 28.00 (SD = 8.89). Sample
characteristics in each of the three groups, including secondary diagnoses and other
medication use, are described in Table 1. The two sites did not significantly differ in terms of
gender, F(2,155) = .168, p = .867, but Yale participants (Mage = 30.04, SD = 8.75) on the
whole were older than Kent State participants (Mage = 19.70, SD = 1.84), t(149.74) =
−12.01, p < .001, given that Yale imposed an additional criterion that excluded current
undergraduates.
Procedures

Author Manuscript
Author Manuscript

Diagnostic Assessment—Prospective participants were scheduled for a diagnostic
interview (Structured Clinical Interview for the DSM-IV—Research Version [SCID-IV-RV];
First et al. 2002) conducted by advanced clinical psychology graduate students who had
completed a rigorous six-month training on diagnostic assessment using the SCID-IV-RV.
Interviewers had to achieve reliability in their diagnoses with experienced diagnosticians
before conducting assessments independently. A proportion of the interviews were videorecorded for training and supervision purposes, and an additional rater (AA) watched a
subset (25 %) of these recordings in order to code for each diagnosis of GAD and depressive
disorders, κ’s from .89 to 1; for other disorders, κ’s from .70 to .85). One departure from the
SCID procedures was that the assessment protocol for the present study disregarded the
hierarchy rule (i.e., GAD that only co-occurs with UDD is an epiphenomenon of depression,
rather than a separate diagnosis), given evidence to suggest that there are few if any
meaningful differences between individuals with a DSM-IV GAD diagnosis and those who
would otherwise meet the diagnostic threshold for GAD except for the hierarchy rule (e.g.,
see Zimmerman and Chelminski 2003).
Experimental Session—Several days after the diagnostic interview, participants returned
for the experimental session during which they completed self-report measures and the
emotional videos task. After a research assistant set up the psychophysiological equipment,
participants sat quietly for a 5-min resting baseline recording. They then viewed the fear,
happy and sad film clips in counterbalanced order. After each of the film clips, participants
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provided state emotion ratings. A physiological recovery period also followed each film,
during which participants remained seated while resting for 2 min. The experimental session
also involved completing several other computerized tasks not described here, which were
counterbalanced with the film clips task. Procedures for the diagnostic interview and
emotional videos task were identical at the two sites. All participants provided informed
consent, and were compensated 30 dollars for their time. The study was approved by the
Institutional Review Boards of Yale University and Kent State University.
Emotion Elicitation—Participants viewed film clips from the movies Silence of the
Lambs (fear), Frequency (happiness), and Return to Me (sadness) that have been widely
used for emotion induction in previous investigations of anxiety and depression (e.g., Aldao
and Mennin 2012; Llera and Newman 2010; Rottenberg et al. 2007). Stimuli were presented
with Superlab 4.0.7 (Superlab, Cedrus, Inc. San Pedro, CA, USA) on a desktop computer.

Author Manuscript

Psychophysiological Set Up—The electrocardiogram (EKG) was recorded using two
disposable pre-gelled 11-mm Ag/AgCl electrodes (EL503; Biopac Systems, Inc., Goleta,
California, USA), connected to an ECG100C amplifier for the MP150 System (Biopac
Systems, Inc.). Respiration and electrodermal activity (not described here) were recorded
simultaneously via their respective transducers. A research assistant helped participants to
secure the strain gauge respiration belt around their chest and place the electrodes for the
EKG in a modified lead-II configuration on their right shoulder and left hip. The EKG was
acquired continuously in AcqKnowledge 3.9 (Biopac Systems, Inc.) and digitized at a
sampling rate of 1 kHz with high- and low-pass filters at .5 and 35 Hz.

Author Manuscript
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Heart Rate Variability—EKG data in each segment (baseline, emotion film clips,
recovery periods) were exported as a series of interbeat intervals (IBIs) in milliseconds from
AcqKnowledge for cleaning and processing using QRSTool and CMetX software (Allen et
al. 2007; http://psychofizz.org). Both programs have shown good field validity (Hibbert et al.
2012). QRSTool interpolates the IBI series in a graphical user interface for semi-automatic
R-peak detection, followed by visual inspection and manual correction of any missed beats.
CMetX calculates various time-domain metrics of HRV from the cleaned data, including the
mean square difference of successive IBIs (MSD), which has previously shown ability to
distinguish GAD from non-GAD participants (e.g., Thayer et al. 1996; Aldao and Mennin
2012; Aldao et al. 2013; Mankus et al. 2013). Data segments containing excessive artifacts
due to movement or interference were excluded from analysis (Berntson and Stowell 1998).
To further reduce the likelihood of artifact contamination, we standardized the resulting
HRV values as Z-scores in SPSS 20.0 (IBM Corp, Armonk, NY) and values more than three
standard deviations from the mean were removed, checked against the CMetX output that
indicates whether any additional artifacts were identified in the cleaned data. MSD values
were positively skewed (skewness statistic [ 2), so we performed a logarithmic
transformation on MSD in each segment, which reduced skewness statistics to 1 or lower.
Subsequently, ‘HRV’ refers to the log10-transformed MSD.
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Baseline Measures—In line with previous studies (e.g., Hofmann et al. 2010) we
administered self-report questionnaires to assess levels of the defining clinical features of
our diagnoses (i.e., worry in GAD; depressive symptoms in UDD).
Beck Depression Inventory-II (BDI-II)—The BDI-II (Beck et al. 1996) is a widely-used
measure of depressive symptom (e.g., anhedonia, irritability, sleep disturbance, tearfulness,
excessive guilt) presence and severity within the previous 2 weeks. BDI scores in the present
sample showed high internal consistency (Cronbach’s α = .93).

Author Manuscript

Penn State Worry Questionnaire (PSWQ)—The PSWQ (Meyer et al. 1990) assesses
the degree to which one’s worry is pervasive, uncontrollable, and excessive, and is
considered a ‘gold standard’ measure of GAD-relevant worry. Cronbach’s α = .95 in the
present sample.
Worry and Rumination Visual Analog Scales (WVAS and RVAS)—In order to
examine whether any observed differences between comorbid and non-comorbid GAD
groups might be a result of differences in worry or rumination at the time of the experiment,
we also asked participants to rate their present level of each at baseline. Participants were
provided with operational definitions of worry and rumination and asked to construct two
visual-analogue scales using idiographic anchors. They provided five scenarios from their
own lives associated with different levels of worry or rumination, from zero (‘none’) to 100
(‘extreme’), then used these as a frame of reference to rate their level of worry and
rumination at that moment. This type of idiographic VAS has previously been used to
measure worry at the state level (e.g., McLaughlin et al. 2007; Aldao et al. 2013).

Author Manuscript

Subjective Emotion Ratings—At baseline and after each of the four film clips,
participants completed a modified Positive and Negative Affect Schedule (PANAS; Watson
et al. 1988) that we expanded to include three different words within each target emotion
(amusement/happiness/joy; dejection/sadness/unhappiness; anxiety/fear/nervousness.) Each
emotion was rated on a nine-point scale from ‘none’ to ‘extreme’ and averaged into
composite scores for happiness (α = .89), sadness (α = .86), and fear (α = .82), all of which
demonstrated excellent internal consistency.

Results
Baseline Measures

Author Manuscript

There was no effect of group (GAD, GAD + UDD, controls) on HRV at baseline, F(2,143) =
1.525, p = .219.
As expected, we observed a significant main effect of group (GAD, GAD + UDD, controls)
on the BDI, F(2,136) = 63.74, p < .001 and PSWQ, F(2,146) = 58.29. BDI scores in the
GAD + UDD group (M = 23.44, SD = 8.31) were significantly greater than in the GAD
group (M = 15.27, SD = 8.51) or in the control group (M = 5.77, SD = 6.13), p ≤ .001.
PSWQ scores did not differ between the GAD group (M = 62.88, SD = 10.75) and the GAD
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+ UDD group (M = 63.62, SD = 9.67), p = 1.000, but were significantly lower in the control
group (M = 40.15, SD = 15.14) than in either GAD or GAD + UDD groups, p < 001.
There was also a significant main effect of the three-level group on baseline ratings for the
RVAS, F(2,141) = 10.60, and WVAS, F(2,141) = 13.75, p < .001. Ratings did not differ
significantly between the GAD group (RVAS: M = 41.79, SD = 29.53, WVAS M = 43.93,
SD = 29.33) compared to the GAD + UDD group (RVAS: M = 54.48, SD = 36.37, WVAS M
= 54.00, SD = 32.29), p ≥ .182. Both groups’ ratings were higher than those in the control
group (RVAS: M = 25.86, SD = 25.86, WVAS: M = 23.35, SD = 25.23), p ≤ .003.
Manipulation Check
We conducted a 2 (baseline versus fear, sad, or happy film clip) × 3 (group) ANOVA for
each of the three composite emotions (fear, sadness, and happiness.) There were significant

Author Manuscript

within-subjects effects of period for fear, F(1,161) = 79.43,

= .33, for sadness, F(1,159) =

180.17, = .53, and for happiness, F(1,159) = 50.28, = .24, all p < .001, such that ratings
for each target emotion were greater during the film clip compared to baseline. Table 2
shows mean ratings and their standard deviations for the three emotions in each period by
group.
Subjective Response to Emotion
We next examined effects of group on the target emotion at baseline and during the film clip
in order assess potential differences in subjective emotion ratings between GAD, GAD +
UDD, and control groups (Table 2).

Author Manuscript

Fear—There was a small though significant effect of group, F(1,161) = 15.12, p = .009,
= .06. Pairwise comparisons showed that baseline fear ratings in the GAD group were higher
than those in the control group, p = .001, but lower than those in the GAD + UDD group, p
= .031. However, fear ratings during the fear clip were similar across groups, p’s ≥ .52.
Sadness—There was a significant effect of group on sad ratings during baseline and the
sad clip, F(1,159) = 7.28, p = .001, = .08, such that sadness ratings both at baseline and
during the sad clip were significantly lower in both the GAD group, p ≤ .048, and the control
group, p ≤ .013, compared to the GAD + UDD group. There was no significant difference in
sadness between the GAD and control groups, p ≥ .621 in either period.
Happiness—There was no between-subjects effect of group on happiness, F(1,159) =

Author Manuscript

1.51, p = .224, = .02, and no differences in happiness between groups either at baseline or
during the happy film clip.
Physiological Response to Emotion
To examine differences in phasic HRV response to emotion as a function of GAD or
comorbid GAD + UDD, we conducted repeated-measures ANOVAs in each of the emotion
elicitations (fear, sadness, or happiness). Descriptive statistics for HRV in each time period
by group are shown in Table 3. Each model predicted HRV in the three time periods over the
Cognit Ther Res. Author manuscript; available in PMC 2016 September 20.
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experiment (baseline, film clip, and recovery) from the three-level group, controlling for age
and medication. F statistics are reported with Greenhouse-Geisser correction where there
was a significant violation of sphericity assumption (Mauchly’s test p < .05). Overall, there
were significant between-subjects effects of age and use of tricyclic antidepressants, SSRI/
SNRIs, and benzodiazepines across the various emotional contexts in all three models (Table
4).
Fear—We found no significant main effect of period, F(2,250) = .57, p = .57,
group, F(2,125) = 1.57, p = .213,

= .005, nor

= .024 on HRV. However, there was an interaction

Author Manuscript

between period and group, F(4,250) = 2.78, = .043, p = .027, such that HRV did not differ
between groups with the exception of during the film clip, where the GAD group showed
significantly lower HRV (M = 1.38, SD = .22) compared to the control group (M = 1.47, SD
= .27), p = .024. There was no change in HRV over time in the GAD group, unlike the
control group who showed a significant increase from HRV to the fear video, p < .001.
There was also a trend for this pattern of lower HRV in the GAD group (M = 1.38, SD = .
22) relative to the control group (M = 1.48, SD = .28) continuing in the recovery period, p
= .086, where HRV in the control group remained elevated relative to their HRV at baseline,
p < .001. There were no differences between the GAD + UDD group and either the control
or GAD groups. HRV in each group over the three time periods is shown in Fig. 1a.
Sadness—We found no significant main effect of period, F(1.88,228.21) = 1.12, p = .329,
= .009, nor group, F(2,121) = 1.90, p = .154,

= .03 on HRV, though there was a just-

Author Manuscript

significant interaction between period and group, F(3.77,228.21) = 2.53, = .04, p = .045.
HRV did not differ significantly between groups at baseline nor during the film clip. During
the recovery period, the GAD group showed lower HRV (M = 1.35, SD = .25) compared to
the control group (M = 1.45, SD = .25), p = .017, as well as the GAD + UDD group (M =
1.44, SD = .24) though only at the trend level, p = .071. Interestingly, HRV in both the GAD
and GAD + UDD groups declined significantly (p’s ≤ .049) from the sad clip to the recovery
period, while HRV in the control group showed no such change, remaining elevated relative
to baseline, p < .001. HRV in each group over the three time periods is shown in Fig. 1b.
Happiness—Again, there were no significant main effects on HRV of either period,

F(1.80,221.44) = 1.10, p = .334, = .009, or group, F(2,123) = 1.38, p = .324, = .018.
However, unlike the negative emotion elicitations, there was no interaction effect, i.e., no

Author Manuscript

differences between groups in any period, F(3.60,221.44) = 0.71, p = .574, = .011.
Despite this finding, we did observe that individuals in the control group showed a
significant increase in HRV from baseline to the happy clip, p < .001, a difference which
was maintained during the recovery period (recovery > baseline p = .014). Although the
GAD also showed an increase in HRV from baseline to the clip, p = .024, their HRV during
the recovery period did not differ significantly from either baseline or the happy clip. The
GAD + UDD group showed no physiological response to the happy clip, as evidenced by no
significant pairwise comparisons for HRV between the three periods, p ≥ .288. HRV in each
group over the three time periods is shown in Fig. 1c.
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The ability to adapt to our mutable environment is fundamental to health and well-being
(e.g., Aldao et al. 2015; Friedman 2007; Gross and Jazaieri 2014; Shaffer et al. 2014). In
order to explore potential differences in emotional responding in GAD as a function of UDD
comorbidity, we presented film clips designed to elicit fear, sadness, and happiness to a large
community sample of individuals with GAD, comorbid GAD + UDD, and or no disorder. In
summary, we observed significant interaction period-by-group effects on HRV during our
negative emotion elicitations (fear and sadness), though not the happy elicitation. Although
there was no difference in HRV between groups at baseline, the GAD group displayed
significantly lower HRV during the fear film clip and sadness recovery period compared to
the control group, while there was no significant difference between the comorbid GAD +
UDD group compared to either the GAD group or controls at any timepoint. There were no
group differences for happiness. Further, when we compared differences among timepoints
within each group, we noticed a pattern of varying phasic responses. In response to all three
emotions, controls’ HRV increased from baseline to the emotion film clip. Controls’ HRV
also remained elevated relative to baseline during the recovery periods for fear and sadness.
HRV in the GAD group also increased from baseline to film clip (in response to sadness and
happiness only); however, individuals with GAD were unable to sustain these increases in
HRV during the recovery period. Finally, the GAD + UDD group showed little phasic
response to emotion apart from a transient increase in response to sadness; however, HRV
did not differ significantly from either the GAD-only or control groups at any timepoint in
the experiment.
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These patterns of physiological responding among the three groups are particularly
interesting in light of our findings with the subjective emotion ratings. Though we found
significant effects of group for fear and sadness ratings, these differences appeared to be
driven primarily by group differences at baseline (fear) or baseline and the clip (sadness).
For both of these emotions, the comorbid group endorsed higher levels of negative affect
relative to both GAD and control groups. At baseline, the GAD group endorsed higher levels
of fear (but not sadness) compared to the control group. There were no differences between
groups in happiness ratings at baseline or during the happy clip. These results might suggest
that pre-existing (i.e., unrelated to the elicitation stimuli) negative affect in individuals in the
GAD + UDD group may have had a dampening effect on their capacity for responding
physiologically to the film clips, in line with the literature showing that depressed
individuals are less sensitive to varying emotional contexts (e.g., Bylsma et al. 2008;
Rottenberg et al. 2005b). It is also notable that, for the control group, HRV was augmented
during the film clips and sustained in the recovery period. In contrast, individuals with GAD
alone showed no phasic change in HRV (fear), or showed a transient increase in HRV, which
ultimately fell back to baseline during the recovery period (sadness; happiness). In GAD,
physiological inflexibility is thought to reflect a defensive and disorganized response style
associated with reliance on avoidance and worry as means to manage intensely-felt emotions
(e.g., Aldao and Mennin 2012; Llera and Newman 2010; Movius and Allen 2005; Thayer et
al. 1996). Although not pathological in and of itself, greater affective intensity may lead
individuals with GAD to adopt a rigid and defensive stance in efforts to cope with emotions
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that feel overwhelming or threatening (e.g., Mennin and Fresco 2014). Further, nondiagnosed individuals with high levels of difficulties in regulating emotions show a pattern
of HRV response similar to that typically found in GAD: in a recent study, although HRV in
both low- and high-difficulties groups decreased in response to negative emotion, the highdifficulties group showed a prolonged decrease that persisted beyond the elicitation into the
recovery period (Berna et al. 2014). Decreased HRV has also been linked to facets of
emotion regulation deficits relevant to GAD—namely lack of emotional clarity and lower
inhibitory control when experiencing negative emotions—even after controlling for anxiety
and other covariates, supporting the link between physiological flexibility and adaptive
response to emotion (Appelhans and Luecken 2006; Williams et al. 2015).
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Greater psychological health is generally associated with a quadratic pattern representing
rapid vagal withdrawal and recovery in response to a stressor. Here we observed an opposite
response, where the film clips were associated with HRV augmentation rather than
withdrawal. Although the patterns of HRV response to emotion observed in our sample may
seem paradoxical, HRV was lowest during baseline for all groups. This may have resulted
from anticipatory stress as participants sat quietly waiting for the experiment to begin in
earnest. People often prefer doing something, including self-administering electric shocks, to
being alone with their thoughts for as little as 6 min (Wilson et al. 2014). Further, higher
HRV has been proposed to index increased self-regulatory effort or the ability to sustain
attention and engage with stimuli in the environment (e.g., Porges et al. 1994; Segerstrom
and Nes 2007), so we might interpret the prolonged increase in HRV in the control group as
indicative of greater ability to self-regulate or to sustain attention compared to the GAD and
GAD + UDD groups. Although speculative in absence of state worry measures during the
film clips and recovery periods, it may be that the periods in which HRV was lower in the
GAD group were those periods which led to greater worry. This could be either due to
efforts in the recovery period to avoid emotions aroused by the film clips—or simply due to
the anticipatory or ambiguous nature of the portions of the experiment that required
participants to simply sit and wait for the next stimulus to occur. The lack of HRV
augmentation in response to the film clips (other than sadness) in the GAD + UDD group
might reflect blunted reactivity (e.g., Bylsma et al. 2008), deficits in motivated attention that
are typically more specific to depression (e.g., Chantiluke et al. 2012), or simply greater
severity in the comorbid group. Though GAD and GAD + UDD groups did not differ on our
measures of worry symptoms (PSWQ) or state worry and rumination (WVAS/RVAS), the
GAD + UDD group reported greater overall subjective negative affect, as well as higher
levels of depressive symptoms (BDI) compared to both GAD-only and control groups.
However, any conclusions regarding differences between the comorbid and non-comorbid
groups should be interpreted with caution, given that we did not find any significant
differences when comparing HRV in the GAD + UDD group to the other two groups.
Our results are qualified by a number of limitations, most notably the lack of a fourth, UDDonly group, which would have allowed us to assess whether observed effects were unique to
depression in the presence of generalized anxiety, or a feature of UDDs themselves. Studies
have shown an inverse association between depression severity and tonic HRV (see Kemp et
al. 2010, for a meta-analysis), and HRV has been suggested to be an indicator of treatment
response (e.g., Balogh et al. 1993; Chambers and Allen 2002) or as a protective factor
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against future depressive episodes under certain conditions (e.g., Hopp et al. 2013). Yet
others have failed to find these relationships (e.g., Rottenberg 2007; Royster et al. 2012).
Heterogeneous samples and methodology may have been one source of such contradictory
findings (Rottenberg 2007; van Zyl et al. 2008). The DSM-5 currently categorizes recurrent
MDD and dysthymia under the umbrella of ‘persistent depressive disorder’ in absence of
meaningful evidence for their differentiation (American Psychiatric Association 2013).
Previous studies have also combined MDD and dysthymia (Aldao et al. 2010; Liverant et al.
2008). However, a notable limitation is that there have been few if any studies directly
comparing HRV in MDD and dysthymia. Future investigations should seek to better
characterize psychophysiological differences (or lack thereof) between individuals with
MDD and dysthymia, given the changes to these diagnoses in the DSM-5. To test whether
there were meaningful differences between the two diagnoses, we ran our HRV analyses in
only in the subsample of GAD + UDD individuals, using specific UDD (MDD versus
dysthymia) as a between-subjects factor. We observed no significant effects of having a
comorbid dysthymia versus comorbid MDD diagnosis (p’s = .164–.675), nor any diagnosis
× period interactions (p’s = .266–.648). However, our sample of 22 individuals with MDD
and 14 individuals with dysthymia may have been underpowered to detect differences.
Indeed, the control group in the present study was substantially larger than either GAD or
GAD + UDD groups, itself an additional limitation. The sample used in this study were
recruited as part of a larger study examining multiple emotion-related phenomena in mood
and anxiety disorders, and the control group was used for multiple purposes within this
larger study. In addition, we elected to drop a number of individuals from the diagnosed
group who had characteristics that made them unsuitable for the present investigation. These
included primary diagnosis of another Axis-I disorder (e.g., social anxiety, panic disorder),
current substance abuse or dependence, or a depression diagnosis accompanied by the
specifier “in full remission” or “in partial remission” that was reflected in a BDI score in the
non-depressed range. These decisions contributed to the size discrepancy between the
control group and the diagnosed groups. Related to this, another limitation is that lifetime
UDD diagnoses were not assessed; therefore it is possible that individuals in the GAD or
control groups may have previously had a depressive episode.

Author Manuscript

Future investigations should employ sufficiently large samples to explore variation within
the UDD diagnosis and whether such variations differentially impact responses to emotion.
For example, we know little about how depression-as-acute but time limited condition
differs from depression-as-chronic mental illness (Monroe and Harkness 2011). Individuals
who experience only a single life-time episode of depression have shown comparable
emotional startle blink modulation to never-depressed controls, in contrast to individuals
with chronic or recurrent forms of depression (Vaidyanathan et al. 2014). Similarly,
melancholic and atypical subtypes of depression have been associated with distinctive
patterns of physiological reactivity and dysregulation (e.g., Fotiou et al. 2003; Penninx et al.
2013). Melancholia has been shown to feature an overactive stress response indexed by
higher heart rate, lower HRV, and elevated serum cortisol, whereas metabolic and
inflammatory dysregulation may be more specific to atypical depression (Kemp et al. 2014b;
Penninx et al. 2013).
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In order to obtain a more complete understanding of how UDD impacts emotional
experience in GAD, it likely will be necessary to measure different aspects of physiological
activity in addition to HRV. For example, Fisher et al. (2010) found increased sympathetic
activity at baseline moderated self-reported physiological arousal in participants with GAD
only, whereas there was no relationship between subjective and physiological arousal in
comorbid GAD. Further, greater anhedonia and motivational deficits in depression were
found to be associated with reduced effort-related sympathetic activity, but were unrelated to
HRV (Silvia et al. 2014). SNS measures may be more relevant to ANS dysregulation in
UDD than HRV: in a recent study, sympathetic vasomotor tone was found to more strongly
predict depressive symptoms than either HRV or blood pressure alone (Sanchez-Gonzalez et
al. 2013). ANS dysregulation in GAD has been widely ascribed to the inhibitory effect of
chronic worry on specifically parasympathetic flexibility (e.g., Lyonfields et al. 1995;
Thayer et al. 1996). Yet the relationship between the SNS and PNS is not necessarily
antagonistic (Cacioppo et al. 2007). Unfortunately, the present study did not include a
reliable measure of sympathetic nervous system (SNS) activity. Although the CMetX
program (Allen et al. 2007) does generate a sympathetic metric, this more accurately indexes
shift in autonomic activity (from PNS-dominant to SNS-dominant) rather than degree, as
other HRV metrics do, therefore we elected not to include this metric in our present
investigation (Toichi et al. 1997). However, future studies should employ reliable measures
of sympathetically-mediated cardiovascular activity such as pre-ejection period (i.e.,
impedance cardiography).
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Future studies should also use emotion elicitation procedures that are sufficiently personally
relevant and engaging in order to invoke stronger and more complex motivational states
(Aldao 2013; Mennin and Fresco 2015). We observed that in general, the film clips did not
elicit ratings commensurate with intense subjective emotions. All three groups showed only
minor changes in subjective emotion in response to the film clips (Table 2). This may
contribute to the small effect sizes associated with the observed changes in HRV and is
congruent with the notion that the film clips generally did not elicit a strong emotional
response in either subjective or physiological domains. Passively-viewed stimuli may suffer
from a lack of personal or motivational relevance, resulting in a less intense emotional
experience (Aldao 2013). It is also possible that the three emotions used here are limited in
their relevance to GAD psychopathology, in which internally-generated images and thoughts
(i.e., worries) may be more evocative than external stimuli (Mennin and Fresco 2015).
Therefore, inducing threat or worry states might have been more effective in producing
physiological changes comparable to those found in previous studies. Many of these studies
involved worry or relaxation inductions—and worry and relaxation have been shown to
increase anxiety in GAD (e.g., Heide and Borkovec 1984; Hofmann et al. 2010).
Despite the limitations described above, and although the effects of the film clips on
subjective and physiological responses were small, the present study has several strengths,
including a large (relative to many investigations of HRV in affective disorders) clinically
diagnosed community sample. Given the centrality of emotion to GAD and UDD
psychopathology, it is important to understand how affective processes such as generation
and regulation are functionally related, as well as how factors such as comorbidity may
moderate these relationships (e.g., Mennin et al. 2008; Mennin and Fresco 2015). The
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present findings supplement the growing literature showing that GAD is associated with
unique emotional and regulatory deficits that differ from deficits found in comorbid GAD +
UDD (or UDD alone). Previous studies found patterns of compensatory neural activity in
MDD during emotional conflict adaptation, versus impaired conflict adaptation in GAD,
blunted emotion-modulated startle-blink in anxiety with comorbid UDD versus anxiety
alone, and increased error-related brain activity in GAD versus GAD with comorbid MDD
(e.g., Etkin and Schatzberg 2011; Taylor-Clift et al. 2011; Weinberg et al. 2012). These
underscore the need to explore how shared characteristics such as negative affectivity might
have different functions depending on clinical presentation. For example, GAD typically
onsets earlier than UDD in comorbid presentations, so it may be that over time, heightened
emotionality could ultimately give way to depressive symptoms such as anhedonia, flattened
affect, and motivational deficits (e.g., Kessler et al. 1996; Mennin et al. 2008).
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Although these findings results should be regarded as preliminary pending independent
replication with a UDD-only group and a stronger emotion elicitation procedure, the lack of
baseline differences in HRV here, in contrast to some previous work (e.g., Chang et al.
2013), supports previous findings that suggest that examining change across various contexts
(e.g., Hofmann et al. 2010) should better allow dysregulated processes that may not be
evident at the tonic level to emerge. For instance, the GAD + UDD group reported elevated
depressive symptoms and negative affect at the time of the experiment, which may suggest
that their observed lack of physiological response to the film clips might be more related to
broader deficits in emotion-related phenomena (e.g., amotivation, anhedonia, and emotion
context insensitivity) which can limit individuals from fully engaging with their
environment. Indeed, in a previous investigation, we found that greater dispositional positive
affect, greater emotional intensity, and approach motivation distinguished GAD from UDD
(Aldao et al. 2010). However, unlike controls, individuals in the GAD group did not sustain
the increases in HRV that we observed between baseline, and happiness and sadness clips.
This could also indicate efforts to avoid attending to emotional stimuli (though does not
fully explain the lack of HRV response to the fear clip.) Although any conclusions based on
group differences remain speculative at present, given the lack of significant differences in
HRV between the GAD-only and comorbid group at any timepoint (and between the
comorbid group and controls); however, we hope that the suggestions raised by these
findings will guide subsequent investigations to consider comorbid UDD as a potentially
important moderator of emotions at a functional level in GAD, even as these disorders share
a number of common features.
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Fig. 1.

a HRV during Baseline, Fear, and Recovery by Group. b HRV during Baseline, Sadness, and
Recovery by Group. c HRV during Baseline, Happiness, and Recovery by Group. Note age
and medications appear as covariates in the model
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Table 1

Author Manuscript

Sample characteristics by diagnostic group
Group
CTL

GAD

GAD + UDD

Male

40.5 (30)

30.6 (15)

35.3 (12)

Female

59.5 (44)

69.4 (34)

64.7 (22)

African-American/black

5.3 (4)

5.2 (3)

11.9 (5)

Asian

7.9 (6)

8.6 (5)

16.7 (7)

Caucasian/white

44.7 (34)

46.6 (27)

38.1 (16)

Hispanic

5.3 (4)

–

7.1 (3)

Native American

–

1 (1.7)

–

Other

3.9 (3)

5.2 (3)

–

(missing or not provided)

32.9 (25)

32.8 (19)

26.2 (11)

Age M (SD)

26.56 (9.07)

28.44 (9.04)

30.75 (7.75)

Attention-deficit disorder

–

1

–

Eating disorder NOS

–

3

1

Obsessive–compulsive disorder

–

2

2

Panic disorder

–

3

5

Post-traumatic stress disorder

–

–

3

Social anxiety disorder

–

11

11

Specific phobia

–

12

11

SSRI/SNRIs

3

5

4

Benzodiazepines

–

1

1

Tricyclic antidepressants

1a

–

–

Hormonal birth control

14

13

4

Antihistamines and allergy

1

2

–

Other (e.g. thyroid, asthma medication)

5

7

3

Demographics % (n)

Author Manuscript

Secondary diagnoses (n)

Medication use (n)

Author Manuscript

Data regarding the racial/ethnic makeup of the Kent sample was not available, so information reported (apart from the ‘missing or not provided’
category) is based on the n = 144 subsample from Yale. NOS = Not Otherwise Specified

a

Amitriptyline is also used for non-psychiatric purposes (e.g., insomnia, pain, migraine treatment) and results of our HRV analyses did not differ
after excluding this individual

Author Manuscript
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Emotion ratings in each period (means and standard deviations)
Period

Group M (SD)
Control

GAD

GAD + UDD

Fear

0.69 (0.97)

1.42 (1.17)

1.92 (1.50)

Happy

1.91 (1.53)

1.74 (1.14)

1.53 (1.27)

Sad

0.33 (0.78)

0.42 (0.76)

1.12 (1.71)

Fear

2.64 (2.08)

2.85 (2.00)

2.97 (2.05)

Happy

1.06 (1.21)

0.92 (1.20)

0.94 (1.25)

Sad

0.46 (0.90)

0.44 (1.02)

1.42 (1.90)

Fear

1.21 (1.32)

1.53 (2.04)

2.32 (1.81)

Happy

1.53 (1.48)

1.20 (1.39)

0.90 (1.05)

Sad

2.15 (1.60)

2.32 (1.76)

3.06 (1.77)

Fear

0.76 (1.31)

1.07 (1.55)

1.77 (1.57)

Happy

3.03 (1.71)

2.70 (1.70)

2.41 (1.35)

Sad

0.37 (0.98)

0.70 (1.54)

1.29 (1.46)

Baseline

Fear clip

Sad clip

Author Manuscript

Happy clip

Emotions were rated on a 10-point scale, where 0 = “none” and 9 = “extreme”

Author Manuscript
Author Manuscript
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HRV in each time period by group (means and standard deviations)
Period M (SD)

Group
Controls

GAD

GAD + UDD

Baseline

1.39 (0.28)

1.35 (0.24)

1.41 (0.22)

Fear clip

1.47 (0.27)

1.38 (0.22)

1.45 (0.20)

Fear recovery

1.46 (0.28)

1.38 (0.22)

1.43 (0.25)

Sad clip

1.48 (0.27)

1.41 (0.23)

1.47 (0.22)

Sad recovery

1.45 (0.25)

1.35 (0.25)

1.44 (0.24)

Happy clip

1.46 (0.29)

1.40 (0.24)

1.43 (0.24)

Happy recovery

1.43 (0.25)

1.39 (0.24)

1.43 (0.21)

Table shows the log-transformed MSD
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Between-subjects effects of age and medication type on HRV

Author Manuscript
Author Manuscript

Fear

F(1,125)

p

η2p

Age*

5.77

.018

.044

Tricyclic antidepressants**

9.06

.003

.068

SSRI/SNRIs*

3.98

.048

.031

Benzodiazepines*

7.98

.006

.060

Hormonal birth control

1.07

.302

.009

Antihistamines/allergy

0.09

.770

.001

Other (misc.)

0.39

.536

.003

Sadness

F(1,123)

p

η2p

Age*

4.88

.029

.039

Tricyclic antidepressants*

5.65

.019

.045

SSRI/SNRIs*

6.09

.015

.048

Benzodiazepines*

6.79

.010

.053

Hormonal birth control

1.28

.261

.010

Antihistamines/allergy

0.93

.337

.008

Other (misc.)

0.78

.378

.006

Happiness

F(1,121)

p

η2p

Age**

11.18

.001

.083

Tricyclic antidepressants*

6.78

.010

.052

SSRI/SNRIs*

6.38

.013

.049

Benzodiazepines*

5.78

.018

.045

Hormonal birth control

0.61

.437

.005

Antihistamines/allergy

1.15

.285

.009

Other (misc.)

0.27

.603

.002

‘Other (misc.)’ category includes other medications such as thyroid or asthma medications

*

p < .05;

**

p < .005
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